elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37360025-2A605FA5-84F3-4072-9EB5-7D93D5E60E68
Q37360025-2A605FA5-84F3-4072-9EB5-7D93D5E60E68
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37360025-2A605FA5-84F3-4072-9EB5-7D93D5E60E68
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
P2860
Q37360025-2A605FA5-84F3-4072-9EB5-7D93D5E60E68
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37360025-2A605FA5-84F3-4072-9EB5-7D93D5E60E68
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a1d192bd2d0fb53ea5a2650b8ce56bf4f611954
P2860
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.